Podcast thumbnail for FDA CDER Small Business and Industry Assistance (SBIA) Chronicles

FDA CDER Small Business and Industry Assistance (SBIA) Chronicles

Claim This Podcast

by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

5.0(1 reviews)
16 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Overview

FDA’s Center for Drug Evaluation and Research Small Business and Industry Assistance (SBIA) podcast provides industry with brief synopses of trending regulatory information.

Language

🇺🇲

Publishing Since

2/26/2019

2 verified contact emails on file for FDA CDER Small Business and Industry Assistance (SBIA) Chronicles

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for Improving Data Quality with Centralized Statistical Monitoring - with Dr. Paul Schuette and Xiaofeng (Tina) Wang

December 13, 2024

Improving Data Quality with Centralized Statistical Monitoring - with Dr. Paul Schuette and Xiaofeng (Tina) Wang

FDA experts Dr. Paul Schuette and Xiaofeng (Tina) Wang share insights on leveraging centralized statistical monitoring to enhance data quality and efficiency in pharmaceutical development.

Episode thumbnail for Audio Transcript | The Need for Artificial Intelligence in Pharmacovigilance with Dr. Robert Ball

November 15, 2024

Audio Transcript | The Need for Artificial Intelligence in Pharmacovigilance with Dr. Robert Ball

Audio podcast for the pharmaceutical industry on The Need for Artificial Intelligence in Pharmacovigilance and the Emerging Drug Safety Technology Program

Episode thumbnail for Considerations for Drug Products that Contain Nanomaterials

May 15, 2024

Considerations for Drug Products that Contain Nanomaterials

Considerations for Drug Products that Contain Nanomaterials

16 total episodes available

Deep-dive analytics for FDA CDER Small Business and Industry Assistance (SBIA) Chronicles

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is FDA CDER Small Business and Industry Assistance (SBIA) Chronicles?

FDA’s Center for Drug Evaluation and Research Small Business and Industry Assistance (SBIA) podcast provides industry with brief synopses of trending regulatory information.

How often does this podcast release new episodes?

This podcast updates weekly.

Where can I listen to this podcast?

This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.